Product Code: ETC13149432 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neurovascular Devices Market was valued at USD 3 Billion in 2024 and is expected to reach USD 4.2 Billion by 2031, growing at a compound annual growth rate of 5.10% during the forecast period (2025-2031).
The Global Neurovascular Devices Market is a rapidly growing sector within the medical devices industry, driven by an increasing prevalence of neurological disorders such as stroke, aneurysms, and brain tumors. These devices include clot retrieval devices, stent retrievers, embolic coils, flow diverters, and neurovascular thrombectomy devices, among others. Technological advancements in minimally invasive procedures, coupled with a rise in the aging population worldwide, are fueling the market growth. North America holds a significant share of the market due to high healthcare expenditure and the presence of key market players. However, the Asia-Pacific region is expected to witness the highest growth rate in the coming years, attributed to improving healthcare infrastructure and rising awareness about neurovascular diseases. Key players in the market include Medtronic, Stryker Corporation, Johnson & Johnson, and Penumbra Inc.
The Global Neurovascular Devices Market is witnessing a growing demand for minimally invasive procedures to treat various neurological disorders such as stroke, aneurysms, and arteriovenous malformations. Technological advancements in neurovascular devices, such as the development of stent retrievers and flow diverters, are providing more effective treatment options with reduced risks for patients. The increasing prevalence of neurological diseases, along with the aging population and rising healthcare expenditure, is driving market growth. Furthermore, the expansion of healthcare infrastructure in emerging economies and rising awareness about early diagnosis and treatment of neurovascular conditions present significant opportunities for market players to expand their presence globally. Collaboration with healthcare providers and investments in research and development for innovative neurovascular devices are key strategies for companies to capitalize on these trends and opportunities in the market.
The Global Neurovascular Devices Market faces several challenges, including stringent regulations and approval processes, limited availability of skilled healthcare professionals trained in using these devices, high cost associated with neurovascular procedures, and the risk of complications during treatment. Additionally, the market is highly competitive with the presence of several key players constantly innovating and introducing new technologies, leading to pricing pressures. Moreover, the complexity of neurovascular procedures and the need for specialized equipment further contribute to the challenges faced by manufacturers and healthcare providers in the market. Addressing these challenges requires continuous investment in research and development, regulatory compliance, training programs for healthcare professionals, and strategic partnerships to navigate the competitive landscape and ensure patient safety and positive outcomes.
The Global Neurovascular Devices Market is primarily driven by the increasing prevalence of neurovascular diseases such as strokes and aneurysms, along with the growing aging population. Technological advancements in neurovascular devices, such as the development of minimally invasive procedures and innovative imaging techniques, are also contributing to market growth. Additionally, rising awareness about the importance of early diagnosis and treatment of neurovascular conditions, coupled with the improving healthcare infrastructure in developing regions, is fueling market expansion. The growing demand for endovascular procedures and the increasing adoption of neurovascular devices by healthcare professionals further boost market growth. Overall, the market is driven by a combination of demographic trends, technological innovations, and the emphasis on improving patient outcomes in neurovascular care.
Government policies related to the Global Neurovascular Devices Market vary by country. In the United States, the FDA regulates neurovascular devices through a rigorous approval process to ensure safety and efficacy. In Europe, the CE marking signifies compliance with European Union regulations. In emerging markets like China and India, regulatory frameworks are evolving to streamline approval processes and ensure product quality. Reimbursement policies also impact market dynamics, with some governments providing coverage for neurovascular procedures, driving market growth. Overall, government policies play a crucial role in shaping the neurovascular devices market by influencing product approval timelines, market access, and reimbursement strategies, creating both opportunities and challenges for industry players.
The Global Neurovascular Devices Market is poised for significant growth in the coming years due to various factors such as increasing prevalence of neurological disorders, advancements in technology, and rising demand for minimally invasive procedures. The market is expected to expand as a result of the growing aging population worldwide and the rising adoption of neurovascular devices for the treatment of conditions like stroke, aneurysms, and arteriovenous malformations. Additionally, ongoing research and development efforts in the field of neurovascular devices are likely to drive innovation and the introduction of more advanced products, further fueling market growth. Emerging economies with improving healthcare infrastructure are also expected to contribute to the market`s expansion. Overall, the Global Neurovascular Devices Market is forecasted to experience steady growth in the foreseeable future.
In the Global Neurovascular Devices Market, North America holds a significant share due to the presence of well-established healthcare infrastructure, high adoption of advanced technologies, and increasing prevalence of neurovascular diseases. Europe follows closely behind with a strong focus on research and development in the field of neurovascular devices. In Asia, the market is rapidly growing driven by improving healthcare facilities, increasing awareness about neurovascular disorders, and rising healthcare expenditure. The Middle East and Africa region is also witnessing growth with a growing emphasis on enhancing healthcare services and infrastructure. Latin America is experiencing a steady increase in demand for neurovascular devices due to improving access to healthcare services and a rising number of neurovascular cases in the region.
Global Neurovascular Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neurovascular Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neurovascular Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neurovascular Devices Market - Industry Life Cycle |
3.4 Global Neurovascular Devices Market - Porter's Five Forces |
3.5 Global Neurovascular Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neurovascular Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Neurovascular Devices Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 Global Neurovascular Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neurovascular Devices Market Trends |
6 Global Neurovascular Devices Market, 2021 - 2031 |
6.1 Global Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neurovascular Devices Market, Revenues & Volume, By Cerebral Embolization and Aneurysm Coiling Devices, 2021 - 2031 |
6.1.3 Global Neurovascular Devices Market, Revenues & Volume, By Cerebral Angioplasty and Stenting Systems, 2021 - 2031 |
6.1.4 Global Neurovascular Devices Market, Revenues & Volume, By Neurothrombectomy Devices, 2021 - 2031 |
6.1.5 Global Neurovascular Devices Market, Revenues & Volume, By Support Devices, 2021 - 2031 |
6.2 Global Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neurovascular Devices Market, Revenues & Volume, By Stroke, 2021 - 2031 |
6.2.3 Global Neurovascular Devices Market, Revenues & Volume, By Cerebral Artery Stenosis, 2021 - 2031 |
6.2.4 Global Neurovascular Devices Market, Revenues & Volume, By Cerebral Aneurysm, 2021 - 2031 |
6.2.5 Global Neurovascular Devices Market, Revenues & Volume, By Other Therapeutic Applications, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Neurovascular Devices Market, Overview & Analysis |
7.1 North America Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
8 Latin America (LATAM) Neurovascular Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
9 Asia Neurovascular Devices Market, Overview & Analysis |
9.1 Asia Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
10 Africa Neurovascular Devices Market, Overview & Analysis |
10.1 Africa Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
11 Europe Neurovascular Devices Market, Overview & Analysis |
11.1 Europe Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
12 Middle East Neurovascular Devices Market, Overview & Analysis |
12.1 Middle East Neurovascular Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neurovascular Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neurovascular Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neurovascular Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Neurovascular Devices Market, Revenues & Volume, By Therapeutic Application, 2021 - 2031 |
13 Global Neurovascular Devices Market Key Performance Indicators |
14 Global Neurovascular Devices Market - Export/Import By Countries Assessment |
15 Global Neurovascular Devices Market - Opportunity Assessment |
15.1 Global Neurovascular Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neurovascular Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Neurovascular Devices Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
16 Global Neurovascular Devices Market - Competitive Landscape |
16.1 Global Neurovascular Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Neurovascular Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |